Are you curious about what’s new in ovarian cancer research? We invite you to join Dr. Premal Thaker, Distinguished Professor and interim Chief of Gynecologic Oncology at Siteman Cancer Center, to hear the latest updates from the Society of Gynecologic Oncology (SGO) Annual Meeting. Dr. Thaker will highlight what the research presented at the conference means for you and answer your questions about the new developments.
Key Takeaways from this Webinar:
- Genetic testing is critical for ovarian cancer patients.
- New options for risk reducing surgery for patients with increased risk of developing ovarian cancer.
- Immunotherapy with upfront chemotherapy has limited benefit.
- Lots of novel antibody drug conjugates in development in ovarian cancer.
